We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CytoDyn Requests EUA for Leronlimab to Treat COVID-19 Patients
CytoDyn Requests EUA for Leronlimab to Treat COVID-19 Patients
Vancouver, Wash.-based drugmaker CytoDyn is seeking an Emergency Use Authorization (EUA) from the FDA for its HIV treatment leronlimab for the treatment of mild-to-moderate COVID-19 patients.